Evidence map›Paper›PMID 41210383›Full record

ReviewEClinicalMedicine2025

Clinical features of Marburg virus disease: a review of all reported patients since 1967.

Raffaella Pisapia, Francesco Maria Fusco, Laura Scorzolini, Luca Fontana, Emanuele Nicastri

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Marburg virus disease outbreak and response in South Ethiopia Region.International journal of emergency medicine · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raffaella PisapiaEmerging Infectious and Highly Infectious Diseases Unit, P.O. D. Cotugno - AORN Ospedali dei Colli, Via Leonardo Bianchi snc, Naples, 80131, Italy.
Francesco Maria FuscoSystemic Infections and Immunocompromised Host Diseases Unit, P.O. D. Cotugno - AORN Ospedali dei Colli, Via Leonardo Bianchi snc, Naples, 80131, Italy.
Laura ScorzoliniHighly Infectious Diseases Isolation Unit, Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Via Portuense 292, 00149 Rome, Italy.
Luca FontanaStrategic Health Operations, Health Emergencies Programme, World Health Organization, Avenue Appia 20, 1211, Geneva, Switzerland.
Emanuele NicastriHighly Infectious Diseases Isolation Unit, Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Via Portuense 292, 00149 Rome, Italy.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Marburg virus disease (MVD) is a severe and often fatal illness caused by the Marburg or Ravn virus. Given the remote areas affected and the infrequency of the disease, the MVD presenting syndromes are unclear, and this may limit timely recognition. Methods: We conducted 333 a literature review of published case reports and outbreak investigations from January 1st, 1967 to October 30th, 2024, to describe the prevalence of MVD-associated symptoms and syndromes. Findings: 722 cases of MVD occurred across 18 outbreaks, with detailed clinical data available for 325 cases. Common symptoms include fever, headache, fatigue, and myalgia; gastrointestinal symptoms are also frequently reported. Haemorrhagic symptoms, mainly hematemesis and bloody diarrhoea, are more specific but less frequent. The overall lethality rate is 72% (95% CI: 68.8-75.0%), dropping to 44% (95% CI: 37.1-50.9%) among PCR-confirmed cases. Interpretation: Variability in prevalent symptoms across different outbreaks complicates early recognition. The lower lethality observed in PCR-confirmed cases may reflect earlier access to appropriate care once Marburg virus disease was recognized, as well as potential misclassification of non-MVD febrile illnesses among unconfirmed cases. Funding: This work was supported by the Italian Ministry of Health, Project P3 - Ricerca Corrente Linea1 - Malattie infettive tropicali e neglette: aspetti patogeneteci, immunologici e diagnostici del Ministero della salute-INMI L.Spallanzani I.R.C.C.S.

Indexed as

Clinical presentationEarly recognitionMarburg viral diseaseSyndromic presentation

Identifiers

PMID41210383
PMCPMC12589951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.